4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-010762
Director sold 65,725 shares at an average $7.48 ($491,850)
From the SEC's structured data for this filing
Trades in this filing
Hallal David · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-10 | Sale : show line 1 in the form | −40,481 | $7.55 | $305,781 | 2,173,085 | D |
| 2022-03-11 | Sale : show line 2 in the form | −25,244 | $7.37 | $186,068 | 2,147,841 | D |
| Open-market sales · 65,725 sh · avg $7.48 · $491,850 | ||||||
Loading xslF345X03/doc4.xml…